Dr. Davide Rubbini, project leader, obtained a BSc and an MSc in Molecular Biotechnology from the University of Bologna and his PhD in Biomedicine from the Universitat Pompeu Fabra (Barcelona). During his PhD he unraveled novel mechanisms underlying inner ear development and regeneration in Zebrafish. Prior to joining Sepsia Therapeutics he led the Central Nervous System department at ZeClinics.